| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2004;109:97-102.)
© 2004 American Heart Association, Inc.
Basic Science Reports |
From the Departments of Surgery, Biochemistry, and Molecular Pharmacology, Thomas Jefferson University College of Medicine (Y.H., T.N.T.); the Department of Physiology, Temple University School of Medicine (S.R.H.) and College of Allied Health Professions (K.E.W.); and the Department of Medicine, Division of Cardiology, MCP-Hahnemann University School of Medicine (J.N.), Philadelphia, Pa.
Correspondence to Thomas N. Tulenko, PhD, Professor, Department of Surgery, Thomas Jefferson University School of Medicine, 1205 Walnut St, Suite 605, Philadelphia, PA 19107. E-mail thomas.tulenko{at}jefferson.edu
Received May 27, 2003; revision received August 25, 2003; accepted September 2, 2003.
Background Although hypercholesterolemia is a well-established risk factor for coronary artery disease, little is known regarding its direct effects on cardiac function.
Methods and Results We examined the effects of cholesterol feeding (0.5%) on cardiac function in rabbits. After 10 weeks, both systolic shortening and diastolic relaxation rates were impaired without any change in aortic pressure or ventricular hypertrophy. However, sarcoplasmic/endoplasmic reticulum Ca2+-ATPase (SERCA)-2 mRNA levels were reduced within 4 days after initiation of cholesterol feeding. After this effect, SERCA-2 protein and SERCA-mediated Ca uptake into sarcoplasmic reticulum vesicles were impaired, and the ratio of MHC-ß to MHC-
mRNA increased 5-fold. Suppression of the SERCA-2 message correlated temporally with enrichment of the cardiac sarcolemma with cholesterol.
Conclusions These data demonstrate that dietary hypercholesterolemia induces a "cholesterol cardiomyopathy" characterized by systolic and diastolic dysfunction. These alterations were independent of vascular disease and demonstrate a dietary link to cardiac dysfunction.
Key Words: heart failure cardiomyopathy myosin sarcoplasmic reticulum hypercholesterolemia
This article has been cited by other articles:
![]() |
R. S. Velagaleti, J. Massaro, R. S. Vasan, S. J. Robins, W. B. Kannel, and D. Levy Relations of Lipid Concentrations to Heart Failure Incidence: The Framingham Heart Study Circulation, December 8, 2009; 120(23): 2345 - 2351. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Chen, O. Ghribi, and J. D. Geiger Rabbits fed cholesterol-enriched diets exhibit pathological features of inclusion body myositis Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2008; 294(3): R829 - R835. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Van den Bergh, A. Vanderper, P. Vangheluwe, F. Desjardins, I. Nevelsteen, W. Verreth, F. Wuytack, P. Holvoet, W. Flameng, J.-L. Balligand, et al. Dyslipidaemia in type II diabetic mice does not aggravate contractile impairment but increases ventricular stiffness Cardiovasc Res, January 15, 2008; 77(2): 371 - 379. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Siegmund, P.-M. Schumm-Draeger, D. Antoni, and H. Von Bibra Beneficial effects of ramipril on myocardial diastolic function in patients with type 2 diabetes mellitus, normal LV systolic function and without coronary artery disease: a prospective study using tissue Doppler Diabetes and Vascular Disease Research, December 1, 2007; 4(4): 358 - 364. [Abstract] [PDF] |
||||
![]() |
H. Mitsuhashi, H. Yatsuya, K. Tamakoshi, K. Matsushita, R. Otsuka, K. Wada, K. Sugiura, S. Takefuji, Y. Hotta, T. Kondo, et al. Adiponectin Level and Left Ventricular Hypertrophy in Japanese Men Hypertension, June 1, 2007; 49(6): 1448 - 1454. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Yue, T. Arai, M. Terashima, A. Y. Sheikh, F. Cao, D. Charo, G. Hoyt, R. C. Robbins, E. A. Ashley, J. Wu, et al. Magnetic resonance imaging of progressive cardiomyopathic changes in the db/db mouse Am J Physiol Heart Circ Physiol, May 1, 2007; 292(5): H2106 - H2118. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Bauersachs, K. Hiss, D. Fraccarollo, U. Laufs, and H. Ruetten Simvastatin improves left ventricular function after myocardial infarction in hypercholesterolemic rabbits by anti-inflammatory effects Cardiovasc Res, December 1, 2006; 72(3): 438 - 446. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2004 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |